Thrivent Financial for Lutherans’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
41,170
+611
| +2% | +$19.3K | ﹤0.01% | 1631 |
|
|
2025
Q1 | $1.33M | Sell |
40,559
-2,123
| -5% | -$69.5K | ﹤0.01% | 1522 |
|
|
2024
Q4 | $1.54M | Sell |
42,682
-591
| -1% | -$21.4K | ﹤0.01% | 1625 |
|
|
2024
Q3 | $1.35M | Sell |
43,273
-2,363
| -5% | -$73.7K | ﹤0.01% | 1719 |
|
|
2024
Q2 | $1.22M | Sell |
45,636
-1,759
| -4% | -$47.1K | ﹤0.01% | 1738 |
|
|
2024
Q1 | $1.62M | Sell |
47,395
-1,287
| -3% | -$43.9K | ﹤0.01% | 1577 |
|
|
2023
Q4 | $1.41M | Sell |
48,682
-1,260
| -3% | -$36.5K | ﹤0.01% | 1628 |
|
|
2023
Q3 | $1.38M | Sell |
49,942
-2,171
| -4% | -$59.9K | ﹤0.01% | 1551 |
|
|
2023
Q2 | $1.57M | Sell |
52,113
-1,459
| -3% | -$43.9K | ﹤0.01% | 1504 |
|
|
2023
Q1 | $1.94M | Sell |
53,572
-1,878
| -3% | -$68K | ﹤0.01% | 1315 |
|
|
2022
Q4 | $1.98M | Buy |
55,450
+151
| +0.3% | +$5.39K | 0.01% | 1268 |
|
|
2022
Q3 | $1.87M | Buy |
55,299
+2,824
| +5% | +$95.6K | 0.01% | 1255 |
|
|
2022
Q2 | $1.52M | Buy |
52,475
+9,182
| +21% | +$266K | ﹤0.01% | 1415 |
|
|
2022
Q1 | $1.4M | Buy |
43,293
+14
| +0% | +$452 | ﹤0.01% | 1580 |
|
|
2021
Q4 | $1.26M | Buy |
43,279
+321
| +0.7% | +$9.36K | ﹤0.01% | 1704 |
|
|
2021
Q3 | $1.15M | Sell |
42,958
-385
| -0.9% | -$10.3K | ﹤0.01% | 1731 |
|
|
2021
Q2 | $1.34M | Sell |
43,343
-131
| -0.3% | -$4.04K | ﹤0.01% | 1663 |
|
|
2021
Q1 | $1.14M | Sell |
43,474
-135
| -0.3% | -$3.53K | ﹤0.01% | 1783 |
|
|
2020
Q4 | $1.1M | Sell |
43,609
-59
| -0.1% | -$1.48K | ﹤0.01% | 1691 |
|
|
2020
Q3 | $910K | Sell |
43,668
-301
| -0.7% | -$6.27K | ﹤0.01% | 1623 |
|
|
2020
Q2 | $1.04M | Hold |
43,969
| – | – | ﹤0.01% | 1468 |
|
|
2020
Q1 | $791K | Buy |
43,969
+2,195
| +5% | +$39.5K | ﹤0.01% | 1442 |
|
|
2019
Q4 | $991K | Buy |
41,774
+100
| +0.2% | +$2.37K | ﹤0.01% | 1499 |
|
|
2019
Q3 | $1.15M | Buy |
41,674
+628
| +2% | +$17.3K | ﹤0.01% | 1319 |
|
|
2019
Q2 | $1.36M | Buy |
41,046
+1,108
| +3% | +$36.7K | ﹤0.01% | 1208 |
|
|
2019
Q1 | $1.4M | Buy |
39,938
+2,854
| +8% | +$100K | ﹤0.01% | 1151 |
|
|
2018
Q4 | $1.23M | Buy |
37,084
+815
| +2% | +$27.1K | ﹤0.01% | 1044 |
|
|
2018
Q3 | $1.83M | Buy |
36,269
+737
| +2% | +$37.1K | 0.01% | 938 |
|
|
2018
Q2 | $2.13M | Buy |
35,532
+860
| +2% | +$51.5K | 0.01% | 885 |
|
|
2018
Q1 | $1.59M | Buy |
34,672
+2,967
| +9% | +$136K | 0.01% | 1003 |
|
|
2017
Q4 | $1.26M | Buy |
31,705
+625
| +2% | +$24.9K | ﹤0.01% | 1121 |
|
|
2017
Q3 | $1.24M | Buy |
31,080
+740
| +2% | +$29.6K | ﹤0.01% | 1059 |
|
|
2017
Q2 | $1.31M | Buy |
30,340
+2,210
| +8% | +$95.3K | 0.01% | 993 |
|
|
2017
Q1 | $880K | Buy |
28,130
+1,850
| +7% | +$57.9K | ﹤0.01% | 1248 |
|
|
2016
Q4 | $664K | Buy |
26,280
+890
| +4% | +$22.5K | ﹤0.01% | 1367 |
|
|
2016
Q3 | $628K | Buy |
25,390
+8,230
| +48% | +$204K | ﹤0.01% | 1351 |
|
|
2016
Q2 | $350K | Buy |
17,160
+1,890
| +12% | +$38.5K | ﹤0.01% | 1588 |
|
|
2016
Q1 | $233K | Buy |
15,270
+450
| +3% | +$6.87K | ﹤0.01% | 1711 |
|
|
2015
Q4 | $199K | Buy |
+14,820
| New | +$199K | ﹤0.01% | 1755 |
|